CERO THERAPEUTICS HOLDINGS, INC. Payments to Acquire Trust Preferred Investments
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Payments to Acquire Trust Preferred Investments of $14.34 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireTrustPreferredInvestments · last filed 2024-04-02
- CERO THERAPEUTICS HOLDINGS, INC. payments to acquire trust preferred investments for the quarter ending 2023-12-31 was $13.89M.
- CERO THERAPEUTICS HOLDINGS, INC. payments to acquire trust preferred investments for the quarter ending 2023-09-30 was $68.85K.
- CERO THERAPEUTICS HOLDINGS, INC. payments to acquire trust preferred investments for fiscal 2023 was $14.34M, a 4311.05% increase from fiscal 2022.
- CERO THERAPEUTICS HOLDINGS, INC. payments to acquire trust preferred investments for fiscal 2022 was $325.00K.
| Period end | Payments to Acquire Trust Preferred Investments 3 month | Payments to Acquire Trust Preferred Investments 6 month | Payments to Acquire Trust Preferred Investments 9 month | Payments to Acquire Trust Preferred Investments 12 month |
|---|---|---|---|---|
| 2023-12-31 | $13.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | $13.96M derived: sum of 2 quarters · filed 2024-04-02 | $14.34M 10-K · filed 2024-04-02 | |
| 2023-09-30 | $68.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $443.85K 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $375.00K 10-Q · filed 2023-08-14 | |||
| 2022-12-31 | $325.00K 10-K · filed 2024-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |